Ben S. Zweifel

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.

Jaime L. Masferrer, Ben S. Zweifel, Pamela T. Manning et al. · Proceedings of the National Academy of Sciences · 1994 · 1.3K citations · Full text

Inflammation, Molecular Pharmacology, Selective Inhibition +14

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.

Jaime L. Masferrer, K. Leahy, Alane Koki et al. · PubMed · 2000 · 1.3K citations

Molecular Pharmacology, Cox-2 Enzyme, Oncology +14

Pharmacological analysis of cyclooxygenase-1 in inflammation

Chris Smith, Yan Zhang, Carol M. Koboldt et al. · Proceedings of the National Academy of Sciences · 1998 · 808 citations · Full text

Inflammation, Anti-inflammatory, Cox-2-derived Pgs +15

4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, Valdecoxib:  A Potent and Selective Inhibitor of COX-2

John J. Talley, David Brown, Jeffery S. Carter et al. · Journal of Medicinal Chemistry · 2000 · 642 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Science +14

Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme.

Jaime L. Masferrer, Karen Seibert, Ben S. Zweifel et al. · Proceedings of the National Academy of Sciences · 1992 · 463 citations · Full text

Immunology, Pharmacotherapy, Glucocorticoid +16